Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-27 Sale | 2021-09-27 7:21 pm | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $175 | $875,000 | 43,509 (Direct) | View |
| 2021-09-23 Sale | 2021-09-24 7:36 pm | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 25,000 | $160.33 | $4,008,127 | 82,238 (Direct) | View |
| 2021-09-21 Sale | 2021-09-22 6:08 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,650 | $150.05 | $997,833 | 18,923 (Direct) | View |
| 2021-09-21 Sale | 2021-09-22 5:56 pm | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $150.03 | $750,150 | 48,509 (Direct) | View |
| 2021-09-08 Sale | 2021-09-09 5:07 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 1,413 | $130 | $183,690 | 18,923 (Direct) | View |
| 2021-07-01 Sale | 2021-07-02 9:15 pm | ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President | 100,000 | $126.83 | $12,682,942 | 640,636 (Direct) | View |
| 2021-04-19 Sale | 2021-04-21 4:46 pm | ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director | 7,500 | $119.26 | $894,425 | 6,044 (Direct) | View |
| 2021-04-05 Sale | 2021-04-05 8:27 pm | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $140.73 | $1,407,343 | 34,499 (Direct) | View |
| 2021-04-05 Sale | 2021-04-05 8:17 pm | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 11,864 | $140.19 | $1,663,156 | 19,457 (Direct) | View |
| 2021-04-01 Sale | 2021-04-02 6:08 pm | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $134.64 | $1,346,382 | 44,499 (Direct) | View |
| 2021-04-01 Sale | 2021-04-02 6:00 pm | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 8,925 | $136.47 | $1,218,003 | 31,321 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 5:17 pm | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $136.01 | $680,059 | 54,396 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-19 Disposition | 2021-11-22 09:12 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 53,907 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:12 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 34,499 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:11 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Malik Kemal Director | 21,178 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:11 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Malik Kemal Director | 1,622 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:10 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Hite Christopher Director | 12,115 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:10 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Hite Christopher Director | 930 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:09 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 22,932 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:09 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 1,622 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:08 am | N/A N/A | ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director | 18,907 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:08 am | N/A N/A | ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director | 6,044 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:08 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director | 31,072 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:08 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director | 6,749 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:07 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Hamill Laura Director | 10,280 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:07 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Hamill Laura Director | 474 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:06 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Nader Francois Director | 74,483 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:06 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Nader Francois Director | 6,749 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:05 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 65,990 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:05 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 23,423 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:04 am | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 95,730 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:04 am | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 18,509 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:04 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 117,859 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:04 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 21,233 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:03 am | N/A N/A | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 77,565 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:03 am | N/A N/A | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 10,681 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:02 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President | 614,281 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:02 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President | 98,450 | $0 | 0 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-12 4:15 pm | N/A 2024-08-01 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 4,500 | $0 | 23,423 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-12 4:15 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 4,500 | $29.37 | 23,423 (Direct) | View |
| 2021-09-27 Exercise | 2021-09-27 7:21 pm | N/A 2028-03-01 | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $0 | 43,509 (Direct) | View |
| 2021-09-27 Exercise | 2021-09-27 7:21 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $40.61 | 43,509 (Direct) | View |
| 2021-09-23 Exercise | 2021-09-24 7:36 pm | N/A 2027-03-02 | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 25,000 | $0 | 82,238 (Direct) | View |
| 2021-09-23 Exercise | 2021-09-24 7:36 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 15,000 | $40.61 | 82,238 (Direct) | View |
| 2021-09-23 Exercise | 2021-09-24 7:36 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 7,500 | $41.64 | 82,238 (Direct) | View |
| 2021-09-23 Exercise | 2021-09-24 7:36 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 2,500 | $30.17 | 82,238 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 6:08 pm | N/A 2027-03-02 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,650 | $0 | 18,923 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 6:08 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 5,200 | $30.17 | 18,923 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 6:08 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 1,450 | $41.2 | 18,923 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 5:56 pm | N/A 2028-03-01 | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $0 | 48,509 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 5:56 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $40.61 | 48,509 (Direct) | View |
| 2021-09-07 Tax Withholding | 2021-09-09 5:07 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 587 | $129.36 | 18,923 (Direct) | View |
| 2021-07-01 Exercise | 2021-07-02 9:15 pm | N/A 2026-12-01 | ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President | 100,000 | $0 | 640,636 (Direct) | View |
| 2021-07-01 Exercise | 2021-07-02 9:15 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President | 100,000 | $35.04 | 640,636 (Direct) | View |
| 2021-06-07 Tax Withholding | 2021-06-08 6:53 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 108 | $126.69 | 20,923 (Direct) | View |
| 2021-02-12 Tax Withholding | 2021-06-08 6:48 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 887 | $130.87 | 18,509 (Direct) | View |
| 2021-04-19 Exercise | 2021-04-21 4:46 pm | N/A 2028-03-01 | ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director | 7,500 | $0 | 6,044 (Direct) | View |
| 2021-04-19 Exercise | 2021-04-21 4:46 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director | 7,500 | $40.61 | 6,044 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-05 8:27 pm | N/A 2023-12-05 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $0 | 34,499 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-05 8:27 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $24.11 | 34,499 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-05 8:17 pm | N/A 2027-11-15 | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 8,925 | $0 | 19,457 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-05 8:17 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 1,875 | $41.64 | 19,457 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-05 8:17 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 5,000 | $35.34 | 19,457 (Direct) | View |
| 2021-04-05 Exercise | 2021-04-05 8:17 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 2,050 | $52.99 | 19,457 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 6:08 pm | N/A 2023-12-05 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $0 | 44,499 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 6:08 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 10,000 | $24.11 | 44,499 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 6:00 pm | N/A 2027-11-15 | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 8,925 | $0 | 31,321 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 6:00 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 1,875 | $41.64 | 31,321 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 6:00 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 5,000 | $35.34 | 31,321 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 6:00 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 2,050 | $52.99 | 31,321 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-04 5:17 pm | N/A 2028-03-01 | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $0 | 54,396 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-04 5:17 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 5,000 | $40.61 | 54,396 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:50 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 23,674 | $0 | 39,837 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:46 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer | 23,674 | $0 | 29,487 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:42 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 26,305 | $0 | 40,292 (Direct) | View |
| 2021-01-04 Exercise(A) | 2021-02-02 7:35 pm | N/A 2028-03-01 | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 10,000 | $0 | 53,987 (Direct) | View |
| 2021-01-04 Exercise(A) | 2021-02-02 7:35 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer | 10,000 | $40.61 | 53,987 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:15 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 26,305 | $0 | 41,677 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:10 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President | 81,023 | $0 | 162,811 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:00 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director | 4,844 | $0 | 37,721 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:52 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Smith Karen L. Director | 4,844 | $0 | 7,783 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:49 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director | 4,844 | $0 | 9,266 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:46 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Malik Kemal Director | 4,844 | $0 | 4,844 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:41 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director | 4,844 | $0 | 9,971 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:38 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Hite Christopher Director | 2,778 | $0 | 2,778 (Direct) | View |